Search research articles
Contact Us
Filters
Showing results (131-140 of 217) with videos related to
Page
of 22
Sort By:
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
March 18, 2017
Phase I/II study of a combination of capecitabine, cisplatin, and intraperitoneal docetaxel (XP ID) in advanced gastric cancer patients with peritoneal metastasis
Hyungwoo Cho, Min-Hee Ryu, Kyu-Pyo Kim, et al.
Cancer Cell International
|
April 25, 2017
Establishment and characterization of 6 novel patient-derived primary pancreatic ductal adenocarcinoma cell lines from Korean pancreatic cancer patients
Mi-Ju Kim, Min-Sun Kim, Sung Joo Kim, et al.
JAMA Network Open
|
February 9, 2024
Epidemiology and Outcomes of Non-Small Cell Lung Cancer in South Korea
Hyun Ae Jung, Dae Ho Lee, Sun Min Lim, et al.
Investigational New Drugs
|
July 12, 2012
Multicenter phase II study of second-line bevacizumab plus doublet combination chemotherapy in patients with metastatic colorectal cancer progressed after upfront bevacizumab plus doublet combination chemotherapy
Yong Sang Hong, Jeeyun Lee, Kyu-pyo Kim, et al.
European Radiology
|
August 27, 2020
CT-determined resectability of borderline resectable and unresectable pancreatic adenocarcinoma following FOLFIRINOX therapy
Jong Keon Jang, Jae Ho Byun, Ji Hun Kang, et al.
Journal of Clinical Medicine
|
May 20, 2020
Reduced and Normalized Carbohydrate Antigen 19-9 Concentrations after Neoadjuvant Chemotherapy Have Comparable Prognostic Performance in Patients with Borderline Resectable and Locally Advanced Pancreatic Cancer
Woohyung Lee, Yejong Park, Jae Woo Kwon, et al.
Translational Lung Cancer Research
|
March 11, 2026
Molecular epidemiology and outcomes of <i>EGFR</i> exon 20 insertion in Korean patients with non-small cell lung cancer
Shinkyo Yoon, Seong-Eun Kim, Sun Min Lim, et al.
Annals of Surgical Oncology
|
November 18, 2016
Microsatellite Instability was not Associated with Survival in Stage III Colon Cancer Treated with Adjuvant Chemotherapy of Oxaliplatin and Infusional 5-Fluorouracil and Leucovorin (FOLFOX)
Jeong Eun Kim, Yong Sang Hong, Hwa Jung Kim, et al.
Oncology
|
February 14, 2012
Genetic polymorphisms of FcγRIIa and FcγRIIIa are not predictive of clinical outcomes after cetuximab plus irinotecan chemotherapy in patients with metastatic colorectal cancer
Seong Joon Park, Yong Sang Hong, Jae-Lyun Lee, et al.
Cancer Research and Treatment
|
May 4, 2023
Analysis of Plasma Circulating Tumor DNA in Borderline Resectable Pancreatic Cancer Treated with Neoadjuvant Modified FOLFIRINOX: Clinical Relevance of DNA Damage Repair Gene Alteration Detection
Dong-Hoon Lim, Hyunseok Yoon, Kyu-Pyo Kim, et al.
Page
of 22
Search research articles
Search
Showing results (131-140 of 217) with videos related to
Sort By:
Page
of 22
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
March 18, 2017
Phase I/II study of a combination of capecitabine, cisplatin, and intraperitoneal docetaxel (XP ID) in advanced gastric cancer patients with peritoneal metastasis
Hyungwoo Cho, Min-Hee Ryu, Kyu-Pyo Kim, et al.
Cancer Cell International
|
April 25, 2017
Establishment and characterization of 6 novel patient-derived primary pancreatic ductal adenocarcinoma cell lines from Korean pancreatic cancer patients
Mi-Ju Kim, Min-Sun Kim, Sung Joo Kim, et al.
JAMA Network Open
|
February 9, 2024
Epidemiology and Outcomes of Non-Small Cell Lung Cancer in South Korea
Hyun Ae Jung, Dae Ho Lee, Sun Min Lim, et al.
Investigational New Drugs
|
July 12, 2012
Multicenter phase II study of second-line bevacizumab plus doublet combination chemotherapy in patients with metastatic colorectal cancer progressed after upfront bevacizumab plus doublet combination chemotherapy
Yong Sang Hong, Jeeyun Lee, Kyu-pyo Kim, et al.
European Radiology
|
August 27, 2020
CT-determined resectability of borderline resectable and unresectable pancreatic adenocarcinoma following FOLFIRINOX therapy
Jong Keon Jang, Jae Ho Byun, Ji Hun Kang, et al.
Journal of Clinical Medicine
|
May 20, 2020
Reduced and Normalized Carbohydrate Antigen 19-9 Concentrations after Neoadjuvant Chemotherapy Have Comparable Prognostic Performance in Patients with Borderline Resectable and Locally Advanced Pancreatic Cancer
Woohyung Lee, Yejong Park, Jae Woo Kwon, et al.
Translational Lung Cancer Research
|
March 11, 2026
Molecular epidemiology and outcomes of <i>EGFR</i> exon 20 insertion in Korean patients with non-small cell lung cancer
Shinkyo Yoon, Seong-Eun Kim, Sun Min Lim, et al.
Annals of Surgical Oncology
|
November 18, 2016
Microsatellite Instability was not Associated with Survival in Stage III Colon Cancer Treated with Adjuvant Chemotherapy of Oxaliplatin and Infusional 5-Fluorouracil and Leucovorin (FOLFOX)
Jeong Eun Kim, Yong Sang Hong, Hwa Jung Kim, et al.
Oncology
|
February 14, 2012
Genetic polymorphisms of FcγRIIa and FcγRIIIa are not predictive of clinical outcomes after cetuximab plus irinotecan chemotherapy in patients with metastatic colorectal cancer
Seong Joon Park, Yong Sang Hong, Jae-Lyun Lee, et al.
Cancer Research and Treatment
|
May 4, 2023
Analysis of Plasma Circulating Tumor DNA in Borderline Resectable Pancreatic Cancer Treated with Neoadjuvant Modified FOLFIRINOX: Clinical Relevance of DNA Damage Repair Gene Alteration Detection
Dong-Hoon Lim, Hyunseok Yoon, Kyu-Pyo Kim, et al.
Page
of 22